IRAK inhibitor 2

Alternative_Names

NA
CAS

928333-30-6
MWt

306.32
Formula

C17H14N4O2
Solubility

10 mM in DMSO
Clinical_Information

No Development Reported
Pathway

Immunology/Inflammation;Protein Tyrosine Kinase/RTK
Target

IRAK;IRAK
Datasheet
SDS
Description

Tissue, pathway, proteinase, peptidase, protease ,acrosin, lipoprotein, activator, caspase, trypsin, papain, esterase inhibitors are proteins or receptor ligands or receptor antagonists that bind to an enzyme receptor and decreases its activity. Since blocking an enzyme's activity can kill a pathogen or correct a metabolic imbalance, many drugs are enzyme inhibitors. Not all receptor antagonist that bind to enzymes are inhibitors; enzyme activator ligands or agonists bind to enzymes and increase their enzymatic activity, while enzyme substrates bind and are converted to products in the normal catalytic cycle of the enzyme.